Market Bizzz

Helping provide confidence to buyers, Nvidia Corp posted positive earnings and surged 14% after forecasting quarterly sales above estimates and reporting a surge in the use of its chips to power artificial intelligence services.

The kiwi continued to draw some support from the Reserve Bank of New Zealand’s hawkish rate rise on Wednesday, after the central bank signalled further tightening ahead to tame high inflation.

Oil has also been pressured by signs of further crude inventory builds. U.S. crude oil and fuel inventories rose by 9.9 million barrels last week, according to market sources citing American Petroleum Institute figures on Wednesday.

However, a general weakening in the final hour of trading pushed both the S&P 500 and the Dow Jones Industrial back into the red. The Nasdaq Composite managed to scrape back into positive territory though in the final moments, ensuring its own losing streak was snapped at three.

On a weekly timeframe, the price has been rising continuously with higher highs and higher lows formation. In addition, the price has been also trading above the 20-days exponential moving averages from the last few weeks indicating a strong bullish trend.

Drug firm Lupin on Tuesday said it has launched a generic anti-psychotic medication in the US market. The company’s product, in strengths of 20 mg, 40 mg, 60 mg, 80 mg and 120 mg, is the generic equivalent of Sunovion Pharmaceuticals Inc’s Latuda tablets.

The rebound in U.S. business activity comes on the back of a recent slew of resilient economic data pointing to a still-tight labour market, sticky inflation and robust retail sales in the world’s largest economy.